The 4 Small Diabetes Diagnostics Companies You Overlooked
Some experts believe large pharmaceutical companies have reached a plateau in market growth. However, that doesn’t tell the whole story, as new companies with disruptive technology have made some significant advancements in 2012.
Read more »How Crowdfunding Affects the Healthcare Market, and Your Wallet
Unlike technology, entertainment, retail and other sectors, novel medical technologies and therapeutics take years of pre-development, and require institutional manpower to further growth.
Read more »Advaxis Nominated for Vaccine Industry Excellence Award
The company has been selected for the shortlist of the 5th Annual Vaccine Industry Excellence (ViE) Awards in the category of Best Therapeutic Vaccine.
Read more »FDA’s Farm Animal Antibiotics Ban Ignored Since 1977, Courts Say
The Food and Drug Administration must act quickly to enforce a largely ignored 35-year-old mandate prohibiting non-medical use of antibiotics in farm animals.
Read more »CS-131: One of the Most Significant Advancements in Brachytherapy
Brachytherapy, a form of radiation therapy where radioactive seeds – or isotopes – are placed near or inside the tumor to emit radiation, is one of the most intriguing both in the medical and investor community.
Read more »Editor’s Note April 3, 2012
Spring represents new beginnings, and while things are just starting to heat up on the outside, the healthcare and life […]
Read more »Crowdfunding: Politicians Love the JOBS Act, Why Investors May Not
Despite political contention over the influence of corporate America in shaping the American Dream, our nation’s leaders tend to unite in their respect of small business.
Read more »Diagnostics in South Asia
India, the world’s largest democracy, has seen dramatic changes in diagnostic developments. The Hindu, a daily newspaper focusing on India and abroad, reported that India has the highest number of multidrug-resistant TB in South East Asia.
Read more »This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Read more »